JFB reviewers evaluate methodological rigor, data transparency, and clinical relevance in submissions. Reviews should be constructive, objective, and aligned with journal policies.

• Diagnostic criteria and outcome accuracy
• Appropriate study design and statistical analysis
• Clarity of outcome definitions and endpoints
• Ethics approvals and patient privacy protections
• Relevance to fertility care and translational impact
• Assess clarity of diagnostic criteria and outcome definitions.
• Verify methodological rigor and appropriate statistical analysis.
• Check adherence to reporting guidelines such as CONSORT or STROBE.
• Comment on clinical relevance and translational impact.
• Review data availability and reproducibility statements.
• Confirm ethics approvals and patient consent disclosures.
• Provide constructive feedback and prioritize major issues.
• Assess whether confounders and biases are addressed.
• Evaluate imaging or laboratory reporting completeness.
• Recommend clarifications for cohort selection or outcomes.
• Check consistency between tables, figures, and text.
• Evaluate whether conclusions overstate clinical implications.
• Suggest improvements to data presentation and figure clarity.
• Assess whether intervention descriptions are sufficient for replication.
• Assess clarity of assay methods and biomarker validation steps.
• Check completeness of treatment protocol descriptions.
• Evaluate reporting of outcome definitions and follow up intervals.

Provide clear recommendations for revisions and highlight major methodological issues. Identify strengths alongside areas for improvement to support authors.

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.